hyperphosphataemia in CKD on dialysis
Renal · 2007–2007
1decision
1medicine
0carried consumer input
0individual submissions
Every decision here pre-dates the consumer comments facility, so no input would be recorded either way.
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| sevelamer hydrochloride treatment of hyperphosphataemia in adults with chronic kidney disease on dialysis, whose serum phosphate is not controlled on other products and where: (a)… | Jul 2007 | Recommended with restriction | no section in document |
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 0 of 0 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.